Jonathan Kurman, MD
Pulmonary Disease · Milwaukee, WINPI 1184913568
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $491,210 of the $802,587 with a category attached, or 61.2%. 34 manufacturers reported payments, led by Pulmonx Corporation at 49.6% of the total. 2025 is the largest year on record at $284,418, more than ten times the $5,484 reported in 2019. Among pulmonary disease clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 737 payments — averaging $1088.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulmonx Corporation$398K
- Ambu A/s$112K
- Verona Pharma, Inc.$104K
- Medtronic$49K
- Ambu Inc.$31K
- Pinnacle Biologics, Inc$28K
- plus $81K from 28 others
Across 25 payments — averaging $11,927 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Galvanize Therapeutics, Inc$183K
- Pulmonx Corporation$96K
- Concordia Laboratories Inc.$15K
- Pinnacle Biologics, Inc$5K
What the payments were for
- Consulting fees$491,21061%
- Speaking & faculty fees$214,71027%
- Travel & lodging$62,9708%
- Food & beverage$27,6073%
- Education$5,7461%
- Gifts$3440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulmonx Corporation | 318 | $398,240 |
| Ambu A/s | 16 | $112,004 |
| Verona Pharma, Inc. | 53 | $103,660 |
| Medtronic | 90 | $48,626 |
| Ambu Inc. | 28 | $30,916 |
| Pinnacle Biologics, Inc | 31 | $27,902 |
| Merit Medical Systems Inc | 17 | $23,196 |
| Cook Incorporated | 15 | $18,321 |
| Boston Scientific | 21 | $10,590 |
| Noah Medical Corporation | 16 | $7,316 |
| Intuitive Surgical | 26 | $7,045 |
| Johnson & Johnson | 34 | $4,434 |
| Steris Corporation | 11 | $1,803 |
| US Endoscopy | 1 | $1,500 |
| Covidien LP | 8 | $1,321 |
| ERBE USA Inc | 3 | $1,183 |
| Verathon Inc. | 1 | $900 |
| Cook Medical LLC | 18 | $626 |
| Galvanize Therapeutics, Inc | 2 | $530 |
| Pentax Of America, Inc. | 1 | $500 |
| BD | 1 | $488 |
| AstraZeneca | 4 | $291 |
| Actelion Pharmaceuticals US, Inc. | 2 | $241 |
| Auris Health, Inc. | 3 | $235 |
| Olympus America Inc. | 4 | $227 |
| Bard Access Systems, Inc. | 2 | $146 |
| United Therapeutics Corporation | 1 | $124 |
| Mylan Specialty L.p. | 3 | $47 |
| 4dmedical USA Inc | 1 | $45 |
| Boehringer Ingelheim | 2 | $36 |
| Mauna Kea Technologies, Inc. | 1 | $32 |
| Olympus Corporation Of The Americas | 1 | $26 |
| Body Vision Medical Inc. | 1 | $24 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPHYR ENDOBRONCHIAL VALVE$389,654
- CHARTIS CATHETER$172,335
- ZEPHYR DELIVERY CATHETER$172,335
- PULMONX CHARTIS TABLET CONSOLE$172,335
- Ohtuvayre$103,476
- ILLUMISITE$40,206
- Photofrin$27,374
- Wayne$8,313
- GENERAL PULMONARY$6,145
- Da Vinci Surgical System$6,043
- Monarch Platform$3,204
- TRUFREEZE$3,038
- Pulmonx Endobronchial Valve EBV$2,941
- Elation Balloon Dilator$2,375
- GALAXY$2,031
- EXALT$2,000
- Aspira$1,425
- GENERAL PAIN MANAGEMENT$1,374
- CRYO$1,108
- Arcpoint$1,034
How this compares
$802,587 in reported general payments places this provider in the 95th percentile of 247 pulmonary disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Milwaukee
- Mouhammed RihawiMilwaukee$713K
- Kurt HuMilwaukee$55K
- Julie BillerMilwaukee$52K
- Mark BarashMilwaukee$52K
- Rahul NanchalMilwaukee$42K
- Steven LehMilwaukee$40K
- Ali MusaniMilwaukee$38K
- Michael KatzoffMilwaukee$37K
- Uzair GhoriMilwaukee$32K
- Jayshil PatelMilwaukee$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.